Breaking News Instant updates and real-time market news.

REGN

Regeneron

$394.87

-2.3 (-0.58%)

09:32
08/06/18
08/06
09:32
08/06/18
09:32

Regeneron price target raised to $400 from $344 at SunTrust

SunTrust analyst Yatin Suneja raised his price target on Regeneron to $400 after its Q2 earnings beat, with Eylea sales robust internationally and Dupixent, Praluent, and Kevzara all performing well. The analyst also keeps his Hold rating, citing competitive headwinds and pricing pressures in the long run. Suneja adds that while Regeneron's disclosure on IO and C5 assets is "intriguing", given the early stage of the assets, he remains neutral on the stock.

  • 11

    Aug

  • 20

    Oct

  • 28

    Oct

REGN Regeneron
$394.87

-2.3 (-0.58%)

08/03/18
BMOC
08/03/18
NO CHANGE
Target $388
BMOC
Market Perform
Regeneron price target raised to $388 from $361 at BMO Capital
BMO Capital analyst Matthew Luchini raised his price target on Regeneron to $388 after its Q2 results showing 'in-line' Eylea sales, a beat from Dupixent, and better than expected earnings coming from lower expenses and taxes. The analyst also attributes the recent improved investor sentiment to a potential weekly SubQ C5 inhibitor, which is expected to start a Phase II trial in 2019. Longer term, the analyst keeps his Market Perform rating on Regeneron given the "concerns about VEGF competitors and key pipeline opportunity uncertainty".
08/03/18
BARD
08/03/18
DOWNGRADE
BARD
Neutral
Regeneron downgraded to Neutral from Outperform at Baird
08/02/18
PIPR
08/02/18
NO CHANGE
Target $450
PIPR
Overweight
Regeneron stock setup 'skewed decidedly to the upside,' says Piper Jaffray
Piper Jaffray analyst Christopher Raymond calls Regeneron Pharmaceuticals' beat in Q2 "impressive." The company is an "emerging operational juggernaut," Raymond tells investors in a post-earnings research note. He believes the stock's setup remains "skewed decidedly to the upside" and keeps an Overweight rating on Regeneron with a $450 price target.
07/19/18
WELS
07/19/18
NO CHANGE
Target $240
WELS
Outperform
Allergan wet AMD data exceed 'unofficial benchmark,' says Wells Fargo
The released efficacy data from Allergan's (AGN) two Phase III trials of its anti-VEGF treatment abicipar in wet age-related macular degeneration looks to have exceeded the "unofficial benchmark set by potential extended-duration competitors," Novartis' (NVS) brolucizumab and Regeneron's (REGN) Eylea, Wells Fargo analyst David Maris tells investors in a research note. The analyst forecasts $125M in sales for abicipar in its first year on the market in 2020 and estimates it will grow to $500M in 2022. Maris keeps an Outperform rating on Allergan with a $240 price target.

TODAY'S FREE FLY STORIES

BXC

BlueLinx

$25.79

0.13 (0.51%)

13:51
03/20/19
03/20
13:51
03/20/19
13:51
Conference/Events
BlueLinx management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

SPG

Simon Property

$173.53

0.11 (0.06%)

13:50
03/20/19
03/20
13:50
03/20/19
13:50
Options
Size put spread in Simon Property Group after a recent dip in shares »

Size put spread in Simon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$26.48

1.33 (5.29%)

13:45
03/20/19
03/20
13:45
03/20/19
13:45
Options
California Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
03/20/19
03/20
13:45
03/20/19
13:45
General news
Breaking General news story  »

FOMC Forecasts to be…

13:45
03/20/19
03/20
13:45
03/20/19
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

PLXS

Plexus

$60.65

-0.48 (-0.79%)

13:44
03/20/19
03/20
13:44
03/20/19
13:44
Initiation
Plexus initiated  »

Plexus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

HIIQ

Health Insurance Innovations

$30.11

-2.52 (-7.72%)

13:40
03/20/19
03/20
13:40
03/20/19
13:40
Recommendations
Health Insurance Innovations analyst commentary  »

Cantor calls Aurelius…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

LEVI

Levi Strauss

$0.00

(0.00%)

13:35
03/20/19
03/20
13:35
03/20/19
13:35
Periodicals
Levi Strauss IPO over 10 times oversubscribed, CNBC reports »

Levi Strauss'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

WLL

Whiting Petroleum

$25.97

1.38 (5.61%)

13:25
03/20/19
03/20
13:25
03/20/19
13:25
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

SPY

SPDR S&P 500 ETF Trust

$280.91

-1.57 (-0.56%)

, SPX

S&P 500

$0.00

(0.00%)

13:17
03/20/19
03/20
13:17
03/20/19
13:17
Periodicals
Trump says tariffs on Chinese goods could stay for a long time, WSJ says »

U.S. President Donald…

SPY

SPDR S&P 500 ETF Trust

$280.91

-1.57 (-0.56%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/20/19
03/20
13:17
03/20/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/20/19
03/20
13:16
03/20/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$71.54

0.15 (0.21%)

13:15
03/20/19
03/20
13:15
03/20/19
13:15
Hot Stocks
Starbucks CEO says company focused on building foundation for next 50 years »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

AEM

Agnico Eagle

$42.80

-0.47 (-1.09%)

13:15
03/20/19
03/20
13:15
03/20/19
13:15
Options
Agnico Eagle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
03/20/19
03/20
13:15
03/20/19
13:15
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

BMWYY

BMW

$0.00

(0.00%)

, F

Ford

$8.50

-0.205 (-2.36%)

13:13
03/20/19
03/20
13:13
03/20/19
13:13
On The Fly
BMW drops after profit slump prediction, peers follow »

German automobile,…

BMWYY

BMW

$0.00

(0.00%)

F

Ford

$8.50

-0.205 (-2.36%)

GM

General Motors

$36.91

-1.36 (-3.55%)

FCAU

Fiat Chrysler

$14.72

-0.4 (-2.65%)

HMC

Honda

$27.46

-0.26 (-0.94%)

TM

Toyota

$119.53

-0.2 (-0.17%)

NSANY

Nissan

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 25

    Apr

  • 30

    Apr

  • 24

    Jul

  • 23

    Oct

TLRD

Tailored Brands

$7.66

-0.41 (-5.08%)

13:05
03/20/19
03/20
13:05
03/20/19
13:05
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$29.13

-3.5 (-10.73%)

12:55
03/20/19
03/20
12:55
03/20/19
12:55
Options
Health Insurance Innovations put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DRI

Darden

$108.53

-1.88 (-1.70%)

, CAG

Conagra Brands

$22.72

-0.09 (-0.39%)

12:53
03/20/19
03/20
12:53
03/20/19
12:53
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$108.53

-1.88 (-1.70%)

CAG

Conagra Brands

$22.72

-0.09 (-0.39%)

CMC

Commercial Metals

$15.86

-0.26 (-1.61%)

GIII

G-III Apparel

$34.73

-0.83 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

MU

Micron

$39.75

-0.63 (-1.56%)

, WSM

Williams-Sonoma

$56.40

-0.39 (-0.69%)

12:53
03/20/19
03/20
12:53
03/20/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

MU

Micron

$39.75

-0.63 (-1.56%)

WSM

Williams-Sonoma

$56.40

-0.39 (-0.69%)

GES

Guess

$22.02

-0.49 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

, AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

12:47
03/20/19
03/20
12:47
03/20/19
12:47
Recommendations
Ulta Beauty, Amazon.com, e.l.f. Beauty, Revlon, Estee Lauder, Coty analyst commentary  »

Amazon risk still…

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

ELF

e.l.f. Beauty

$9.73

0.495 (5.36%)

REV

Revlon

$19.49

1.47 (8.16%)

EL

Estee Lauder

$158.67

-2.03 (-1.26%)

COTY

Coty

$11.42

-0.08 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

  • 01

    May

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$281.08

-1.4 (-0.50%)

12:43
03/20/19
03/20
12:43
03/20/19
12:43
Periodicals
Trump says tariffs on China could last for long period of time »

President Trump, speaking…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$281.08

-1.4 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$113.52

-0.22 (-0.19%)

12:40
03/20/19
03/20
12:40
03/20/19
12:40
Options
Deal hedge opened in Spark Therapeutics »

Deal hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$19.29

0.07 (0.36%)

, LBTYA

Liberty Global

$26.07

-0.08 (-0.31%)

12:39
03/20/19
03/20
12:39
03/20/19
12:39
Periodicals
EC to issue statement of objections on Vodafone, Liberty deal, Reuters says »

EU antitrust regulators…

VOD

Vodafone

$19.29

0.07 (0.36%)

LBTYA

Liberty Global

$26.07

-0.08 (-0.31%)

LBTYK

Liberty Global

$25.40

-0.06 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$39.81

-0.57 (-1.41%)

, SSNLF

Samsung

$0.00

(0.00%)

12:37
03/20/19
03/20
12:37
03/20/19
12:37
Earnings
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$39.81

-0.57 (-1.41%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.